Check if your research matches the topics covered in Cancer Biotherapy and Radiopharmaceuticals?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Researcher.Life는 에디티지의 20년 동안 축적한 출판계와 연구자들의 요구를 심층 있게 파악한 것을 바탕으로 구축된 플랫폼입니다.
Overview | |
Publisher | MARY ANN LIEBERT, INC |
Language | English |
Frequency | Monthly |
General Details | |
Language | English |
Frequency | Monthly |
Publication Start Year | 1996 |
Publisher URL | Visit website |
Website URL | Visit website |
Upload your Manuscript to get
Cancer Biotherapy and Radiopharmaceuticals has been in operation since 1996 till date.
Cancer Biotherapy and Radiopharmaceuticals published with a Monthly frequency.
In 2023, Cancer Biotherapy and Radiopharmaceuticals publsihed 5 articles.
For Cancer Biotherapy and Radiopharmaceuticals, eISSN is 1557-8852 and pISSN is 1084-9785.
Citescore for Cancer Biotherapy and Radiopharmaceuticals is 5.2.
H Index for Cancer Biotherapy and Radiopharmaceuticals is 66.
SNIP score for Cancer Biotherapy and Radiopharmaceuticals is 0.71.
SJR for Cancer Biotherapy and Radiopharmaceuticals is Q2.
MARY ANN LIEBERT, INC is the publisher of Cancer Biotherapy and Radiopharmaceuticals.